Conrad Siegel Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Conrad Siegel Investment Advisors's LLY Position: Q2 2026 in Review
Conrad Siegel Investment Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $6.13K and bringing the position to 350 shares worth $420K. The position accounts for 0.07% of the portfolio, ranked #51.
Conrad Siegel Investment Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Conrad Siegel Investment Advisors held 350 shares of Eli Lilly worth $420K as of Q2 2026.
- Conrad Siegel Investment Advisors bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
- Eli Lilly made up 0.07% of Conrad Siegel Investment Advisors's portfolio in Q2 2026, its #51 holding.
- Conrad Siegel Investment Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Conrad Siegel Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.